Mehta Nikhil, Desai Sanjay M, Dhakad Vinod, Patel Dhruv, Saldanha Elroy
Department of surgical Onology, Sri Aurobindo Institute of Medical Sciences, Bhanwarsala, Indore, 453555 India.
Indian J Surg Oncol. 2020 Sep;11(3):418-422. doi: 10.1007/s13193-020-01103-9. Epub 2020 Jun 5.
Chemotherapy drugs are the integral part of cancer treatment. Their administration is optimized by central venous access devices. We present our prospective study of chemoport implantation by external jugular vein cutdown technique. We studied 100 patients who underwent chemoport insertion over a span of 3 years for various solid and haematological malignancies via external jugular vein cutdown method. Outcomes such as type of disease, anaesthesia, choice of venous access, catheter tip position, length of the procedure, time to start chemotherapy and morbidity data were analysed. The Hundred /100 intravenous devices were implanted in 66% females and 33% males. Most common indication was breast cancer (64% of patients). A total of 80% of patients underwent procedure under local anaesthesia. Chemoports were inserted on the right side in 84 and left side in the remaining 16. The average surgical time was 32 min. The overall success rate was 97% with no intraoperative complications. Three postoperative complications were encountered due to displacement of catheter or wound infection. External jugular vein cutdown approach is a safe, reliable method for venous access device implantation. This approach has a high success rate and has minimal complications and can be easily learnt.
化疗药物是癌症治疗的重要组成部分。通过中心静脉通路装置可优化其给药方式。我们展示了通过颈外静脉切开技术进行化疗端口植入的前瞻性研究。我们研究了100例患者，他们在3年时间里通过颈外静脉切开法因各种实体瘤和血液系统恶性肿瘤接受了化疗端口植入。分析了疾病类型、麻醉方式、静脉通路选择、导管尖端位置、手术时长、开始化疗的时间以及发病率数据等结果。100个静脉装置植入了66%的女性和33%的男性体内。最常见的适应症是乳腺癌（占患者的64%）。共有80%的患者在局部麻醉下接受手术。化疗端口84个插在右侧，其余16个插在左侧。平均手术时间为32分钟。总体成功率为97%，无术中并发症。术后因导管移位或伤口感染出现了3例并发症。颈外静脉切开法是一种安全、可靠的静脉通路装置植入方法。该方法成功率高，并发症极少，且易于掌握。
